Tudor Investment Corp’s iShares Biotechnology ETF IBB Stock Holding History

Tudor Investment Corp’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,963	Closed	-$1.51M	–	3928
2025 Q4	$1.51M	Buy	8,963 +2,513	+39%	+$408K	﹤0.01%	2009
2025 Q3	$931K	Buy	+6,450	New	+$880K	﹤0.01%	2320
2025 Q2	–	Sell	-1,723	Closed	-$220K	–	3470
2025 Q1	$220K	Buy	+1,723	New	+$234K	﹤0.01%	2807
2024 Q4	–	Sell	-9,423	Closed	-$1.37M	–	3235
2024 Q3	$1.37M	Sell	9,423 -2,634	-22%	-$381K	0.01%	1435
2024 Q2	$1.65M	Buy	+12,057	New	+$1.61M	0.01%	1179
2024 Q1	–	Sell	-8,224	Closed	-$1.12M	–	2454
2023 Q4	$1.12M	Buy	+8,224	New	+$1M	0.01%	1385
2022 Q1	–	Sell	-1,465	Closed	-$224K	–	2304
2021 Q4	$224K	Buy	+1,465	New	+$227K	﹤0.01%	2078
2021 Q3	–	Sell	-2,166	Closed	-$354K	–	2611
2021 Q2	$354K	Buy	+2,166	New	+$334K	0.01%	1292
2017 Q3	–	Sell	-234,000	Closed	-$24.2M	–	1165
2017 Q2	$24.2M	Buy	+234,000	New	+$23M	0.74%	18
2017 Q1	–	Sell	-300,000	Closed	-$26.5M	–	1455
2016 Q4	$26.5M	Buy	+300,000	New	+$27.3M	0.68%	17

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tudor Investment Corp's IBB Position: Q1 2026 in Review

Tudor Investment Corp sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 8,963 shares — an estimated $1.51M sold.

Tudor Investment Corp first reported a position in IBB in Q4 2016 and held it in 10 quarters. The position peaked at $26.5M in Q4 2016. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Tudor Investment Corp reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Tudor Investment Corp sold 8,963 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.51M.
Tudor Investment Corp first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 10 quarters.
Tudor Investment Corp's iShares Biotechnology ETF position peaked at $26.5M in Q4 2016.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.